This landscape features major pharmaceutical companies developing GLP-1 therapies, service providers supporting clinical trials, regulatory agencies overseeing safety and efficacy, and end users such as hospitals, clinics, and home care settings
Epitalon is a multi-pathway geroprotector: Unlike most interventions that hit a single hallmark of aging, Epitalon acts on five: telomere maintenance, epigenetic regulation, oxidative stress resilience, immune recalibration, and circadian rhythm restoration, making it one of the broadest-reaching peptides studied in longevity science
But the metabolic slowdown is real, and willpower can't overcome biology
This condition is sometimes referred to as secondary trimethylaminuria , meaning it is brought on by a supplement or diet rather than a primary genetic liver defect [12] [13]
Tesamorelin operates through an entirely different pathway
My honest read after watching a lot of people go through this: the plateau is less a metabolic event than a psychological one